General
Oxford and Serum Institute Ebola vaccine joins clinical trials
Reported by Aditya Chauhan (Staff Writer) · Hindustan Times - India ·
Two new candidate vaccines, including one developed by Oxford University and the Serum Institute of India, have joined ongoing Ebola clinical trials in the Democratic Republic of the Congo. The World Health Organisation states this is the first time vaccines specifically designed against the Bundibugyo virus, which caused the current outbreak, are being tested during an active outbreak.
Trial Details
The trials are part of the ongoing Tumaini study, led by the Institut National de Recherche Biomédicale in the DRC. The study uses a ring-vaccination approach to enroll people who came into contact with confirmed cases. The Coalition for Epidemic Preparedness Innovations funded the rapid development of these candidate vaccines.
Context
Clinical trials are careful research studies conducted with human volunteers to test if new medical treatments or vaccines are safe and effective before they can be given to the general public. Epidemics caused by viruses like Ebola require international scientific cooperation and rapid vaccine development to protect frontline health workers and communities.
More in General

GeneralSource: The HinduWorth knowing
Gurdaspur policeman killed in latest attack as total police deaths reach six this year.
Reported by Pooja Nair (Section Editor) · The Hindu - National ·
